The latest research from Fore Pharma, Global Sickle Cell Disease Clinical Trial Pipeline Highlights – 2020, provides most up-to-date information on key pipeline products in the global Sickle Cell Disease market. It covers emerging therapies for Sickle Cell Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this research helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Research Scope:
– Products by Clinical Trial Stages: Sickle Cell Disease pipeline products by clinical trial stages including both early and late stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
– Drug Mechanism Classes: Sickle Cell Disease pipeline products by their dominant mechanism of action / drug class. This helps executives categorize products based on their drug class.
– Company: Sickle Cell Disease pipeline products by developing company.
– Short-term Launch Highlights: Find out which Sickle Cell Disease pipeline products will be launched in the US and Ex-US till 2025.
Summary of Contents:
– Sickle Cell Disease phase 3 clinical trial pipeline products
– Sickle Cell Disease phase 2 clinical trial pipeline products
– Sickle Cell Disease phase 1 clinical trial pipeline products
– Sickle Cell Disease preclinical research pipeline products
– Sickle Cell Disease discovery stage pipeline products
– Sickle Cell Disease pipeline products short-term launch highlights
Table of Contents
1. Sickle Cell Disease Pipeline by Stages
2. Sickle Cell Disease Phase 3 Clinical Trial Insights
3. Sickle Cell Disease Phase 2 Clinical Trial Insights
4. Sickle Cell Disease Phase 1 Clinical Trial Insights
5. Sickle Cell Disease Preclinical Research Insights
6. Sickle Cell Disease Discovery Stage Insights
7. Appendix
8. Research Methodology
List of Tables
Table 1: Sickle Cell Disease Phase 3 Clinical Trials, 2020
Table 2: Sickle Cell Disease Phase 2 Clinical Trials, 2020
Table 3: Sickle Cell Disease Phase 1 Clinical Trials, 2020
Table 4: Sickle Cell Disease Preclinical Research, 2020
Table 5: Sickle Cell Disease Discovery Stage, 2020
List of Figures
Figure 1: Sickle Cell Disease Pipeline Molecules by Clinical Trials Stage, 2020
Figure 2: Sickle Cell Disease Phase 3 Clinical Trial Highlights, 2020
Figure 3: Sickle Cell Disease Phase 2 Clinical Trial Highlights, 2020
Figure 4: Sickle Cell Disease Phase 1 Clinical Trial Highlights, 2020
Figure 5: Sickle Cell Disease Preclinical Research Highlights, 2020
Figure 6: Sickle Cell Disease Discovery Stage Highlights, 2020
Format
Default dispatch format is PDF.